Norgine BV, a leading specialist pharmaceutical company with a direct commercial presence in all major European markets, announced marketing authorisation for Plenvu for bowel cleansing in adults prior to any procedure requiring a clean bowel has been granted by the Austrian, French, Irish, Italian and Portuguese regulatory authorities. The approval was granted under the European decentralised procedure, with the UK as reference state. Plenvu has also been approved in Australia. Norgine anticipates launches in these countries in 2018.